More on the Tax-Cuts-and-Medicaid-Cuts Bill, Including an Apex Analysis of a Biotech-Boosting R&D Tax Provision
Shares:
It’s the New Year. It’s a time to refresh and reflect and reconnect. In that spirit, I have two asks of you: First: If you find the newsletter useful, please
It’s still all mostly politics out there, with heat but no light when it comes to the topics that we’re focused on here. So most of the newsletter is deep
If you want to search Cost Curve back issues or link to anything you read here, the web links and archive are online at costcurve.beehiiv.com. You can subscribe there, too.